← Back to Clinical Trials
Recruiting NCT06603103

NCT06603103 Prospective Randomized Study Comparing the SpheriKA® (MEDACTA) and Origin® (SYMBIOS) Prostheses During Total Knee Replacement Using the Kinematic Alignment Technique

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06603103
Status Recruiting
Phase
Sponsor Clinique du Sport, Bordeaux Mérignac
Condition Knee Osteoarthritis
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2024-10-03
Primary Completion 2028-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
SPHERIKA prosthesisORIGIN prosthesis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2024-10-03 with a primary completion date of 2028-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The traditional technique for implanting a total knee prosthesis, known as mechanical alignment, does not aim to preserve the original anatomy and laxity of the knee. Instead, the implants are "systematically" aligned to create a non-naturally straight lower limb. Respectively 20% and 50% of patients with a mechanically aligned total knee prosthesis are dissatisfied with the result, and complain of residual symptoms. A newer, more physiological technique for implanting a total knee prosthesis, known as kinematic alignment, aims to recreate the unique native anatomy and laxity of each patient\'s knee. The kinematic alignment technique has been shown to reduce the risk of residual symptoms and thus improve the patient\'s experience of his or her prosthetic knee. As a result of the emergence of the kinematic alignment technique, two manufacturers have developed total knee prosthesis implants specifically for this new insertion technique. A "made-to-measure" total knee prosthesis (ORIGIN® - Symbios, Yverdon-les-Bains, Switzerland) was developed with the aim of reproducing the unique contour of each implanted knee. Another manufacturer opted to develop a generic total knee prosthesis implant (SPHERIKA® - Medacta, Castel San Pietro, Switzerland), but with a design optimized for the kinematic alignment technique. These two models of total knee prosthesis each offer advantages and limitations that need to be assessed. The main aim of this study is therefore to compare the joint perception of these 2 prostheses. It will also look at the clinical and imaging results, the biomechanics of the prosthetic knee during gait, and the muscular strength of knee extension, obtained for these 2 total knee prostheses.

Eligibility Criteria

Inclusion Criteria: * Patient with indication for initial total knee replacement * Patient affiliated to a social security scheme * Patient informed of the study and formally included (informed consent signed) before the first research examination. Exclusion Criteria: * Patient with complex osteoarthritis (e.g. bone loss, history of patellar instability) * Patient with contralateral knee prosthesis * Patient with symptomatic osteoarthritis (stiffness and/or pain) of a hip or contralateral knee * Patient with another condition (acquired pathology) of the lower limbs and/or nervous system that may significantly affect gait quality * Patient deprived of liberty by judicial or administrative decision, * Patient of legal age under legal protection or unable to express consent.

Contact & Investigator

Central Contact

Charles Rivière, MD

✉ charles.riviere@bari-arthroplasty.com

📞 +335 56 46 32 33

Frequently Asked Questions

Who can join the NCT06603103 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06603103 currently recruiting?

Yes, NCT06603103 is actively recruiting participants. Contact the research team at charles.riviere@bari-arthroplasty.com for enrollment information.

Where is the NCT06603103 trial being conducted?

This trial is being conducted at Mérignac, France.

Who is sponsoring the NCT06603103 clinical trial?

NCT06603103 is sponsored by Clinique du Sport, Bordeaux Mérignac. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology